MENU
ABCL
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

AbCellera Biologics (ABCL) Earnings Date & Reports

AbCellera Biologics Inc is an antibody discovery and development engine that’s specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to the clinic and patients sooner... Show more

A.I. Advisor
published Earnings

ABCL is expected to report earnings to rise 12.50% to -13 cents per share on November 11

AbCellera Biologics ABCL Stock Earnings Reports
Q3'25
Est.
$-0.14
Q2'25
Beat
by $0.02
Q1'25
Missed
by $0.01
Q4'24
Beat
by $0.01
Q3'24
Beat
by $0.01
The last earnings report on August 07 showed earnings per share of -11 cents, beating the estimate of -14 cents. With 4.43M shares outstanding, the current market capitalization sits at 1.37B.
View a ticker or compare two or three
ABCL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. ABCL showed earnings on August 07, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
2215 Yukon Street
Phone
+1 604 559-9005
Employees
586
Web
https://www.abcellera.com